What is it about?
In our manuscript, we explained the difference from the validation , troubleshoooting, training point of view between a kit ready to use and a development of an in-house method for LC-MS/MS.
Featured Image
Read the Original
This page is a summary of: The pathway through LC-MS method development: in-house or ready-to-use kit-based methods?, Clinical Chemistry and Laboratory Medicine (CCLM), February 2020, De Gruyter,
DOI: 10.1515/cclm-2019-0916.
You can read the full text:
Contributors
Be the first to contribute to this page
